Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly FCF Margin of 9.85% for Q1 2026, down 607.0% year-over-year from 1.94% in Q1 2025, and up 47.16% quarter-over-quarter from 18.65% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) FCF Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 9.85% for Q1 2026.
- In Q1 2026, FCF Margin fell 607.0% year-over-year to 9.85%; the TTM figure through Mar 2026 stood at 21.12% (down 1995.0% YoY), while the FY2026 annual figure was 21.12%, down 1995.0% from the prior year.
- FCF Margin for Q1 2026 stood at 9.85%, up from 18.65% in the prior quarter.
- The five-year high for FCF Margin was 15.8% in Q4 2024, with the low at 87.29% in Q1 2023.
- The 5-year median for FCF Margin is 18.65% (2025), against an average of 25.84%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin jumped 9224 bps in 2024, then plunged 3444 bps in 2025.
- Sonoma Pharmaceuticals' FCF Margin stood at 12.87% in 2022, then tumbled by 174 bps to 35.21% in 2023, then jumped by 145 bps to 15.8% in 2024, then plunged by 218 bps to 18.65% in 2025, then surged by 47 bps to 9.85% in 2026.
- Business Quant data shows SNOA's FCF Margin at 9.85% in Q1 2026, 18.65% in Q4 2025, and 11.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | -10.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.16% |
| Mar 31, 2026 | -9.85% |
| Dec 31, 2025 | -18.65% |
| Sep 30, 2025 | -11.51% |
| Jun 30, 2025 | -52.83% |
| Mar 31, 2025 | -3.78% |
| Dec 31, 2024 | 15.80% |
| Sep 30, 2024 | 9.16% |
| Jun 30, 2024 | -27.04% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | -35.21% |
| Sep 30, 2023 | -45.15% |
| Jun 30, 2023 | -6.77% |
| Mar 31, 2023 | -87.29% |
| Dec 31, 2022 | -12.87% |
| Sep 30, 2022 | -55.69% |
| Jun 30, 2022 | -39.07% |
| Mar 31, 2022 | -63.40% |
| Dec 31, 2021 | -11.27% |
| Sep 30, 2021 | -35.50% |